îæ€çŽ¢
îæ€çŽ¢
î
Kamada Ltd
KMDAîãŠã©ãããªã¹ãã«è¿œå
7.710USD
-0.315-3.93%
çµå€Â 05/15, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
444.72Mæ䟡ç·é¡
22.00çŽè¿12ã¶æPER
î
詳现æ å ± Kamada Ltd äŒæ¥å
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Kamada Ltdã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãKMDA
äŒç€ŸåKamada Ltd
äžå Žæ¥Aug 01, 2005
æé«çµå¶è²¬ä»»è
ãCEOãLondon (Amir)
åŸæ¥å¡æ°374
蚌åžçš®é¡Ordinary Share
決ç®ææ«Aug 01
æ¬ç€Ÿæåšå°2 Holtzman St., Science Park
éœåžREHOVOT
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœIsrael
éµäŸ¿çªå·7670402
é»è©±çªå·97289406472
ãŠã§ããµã€ãhttps://www.kamada.com/
äŒæ¥ã³ãŒãKMDA
äžå Žæ¥Aug 01, 2005
æé«çµå¶è²¬ä»»è
ãCEOãLondon (Amir)
Kamada Ltdã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
--
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Dr. Ruth Wolfson
Dr. Ruth Wolfson
Senior Vice President - Scientific Affairs
Senior Vice President - Scientific Affairs
--
--
Ms. Pnina Strauss
Ms. Pnina Strauss
Vice President - Inhalation programs & IP
Vice President - Inhalation programs & IP
--
--
Mr. Tuvia Shoham
Mr. Tuvia Shoham
Independent Director
Independent Director
--
--
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
--
--
DR. Naveh Tov
DR. Naveh Tov
Vice President-Clinical Development and Medical
Director for Pulmonary Diseases
Vice President-Clinical Development and Medical
Director for Pulmonary Diseases
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
--
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Dr. Ruth Wolfson
Dr. Ruth Wolfson
Senior Vice President - Scientific Affairs
Senior Vice President - Scientific Affairs
--
--
åçå èš³
é貚: USDæŽæ°æå»: Mon, Apr 6
é貚: USDæŽæ°æå»: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
å°åå¥USD
äŒç€Ÿå
åç
æ¯ç
U.S.A
99.64M
55.22%
Israel
29.56M
16.38%
Latin America
24.22M
13.42%
Canada
10.80M
5.99%
Europe
9.45M
5.24%
ä»ã®
6.78M
3.75%
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Thu, May 14
æŽæ°æå»: Thu, May 14
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
First Israel Mezzanine Investors Ltd.
38.29%
Gov Financial Holdings, Ltd.
4.86%
Phoenix Investment and Finances Ltd
2.87%
Renaissance Technologies LLC
1.46%
Recanati (Leon Yehuda)
1.09%
ä»ã®
51.44%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
First Israel Mezzanine Investors Ltd.
38.29%
Gov Financial Holdings, Ltd.
4.86%
Phoenix Investment and Finances Ltd
2.87%
Renaissance Technologies LLC
1.46%
Recanati (Leon Yehuda)
1.09%
ä»ã®
51.44%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Private Equity
38.29%
Corporation
4.86%
Investment Advisor
4.02%
Investment Advisor/Hedge Fund
2.39%
Hedge Fund
2.39%
Individual Investor
2.34%
Research Firm
1.57%
Pension Fund
0.14%
Venture Capital
0.03%
ä»ã®
43.99%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Apr 1
æŽæ°æå»: Wed, Apr 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q1
98
28.17M
48.83%
-2.16M
2025Q4
90
28.70M
49.76%
-1.24M
2025Q3
77
26.81M
46.48%
-3.11M
2025Q2
80
32.16M
55.76%
-1.16M
2025Q1
80
31.87M
55.42%
-1.29M
2024Q4
72
32.96M
57.32%
-768.38K
2024Q3
87
33.30M
57.92%
-790.28K
2024Q2
91
33.17M
57.70%
-784.97K
2024Q1
93
32.46M
56.47%
-1.61M
2023Q4
102
32.56M
56.63%
-1.63M
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
First Israel Mezzanine Investors Ltd.
22.08M
38.29%
--
--
Dec 31, 2024
Gov Financial Holdings, Ltd.
2.80M
4.86%
-2.00
-0.00%
Dec 31, 2025
Phoenix Investment and Finances Ltd
1.65M
2.87%
--
--
Dec 31, 2025
Renaissance Technologies LLC
839.30K
1.46%
-32.68K
-3.75%
Dec 31, 2025
Recanati (Leon Yehuda)
631.14K
1.09%
--
--
Dec 31, 2025
Tsur (David)
607.93K
1.05%
--
--
Dec 31, 2024
Wells Fargo Advisors
603.62K
1.05%
-2.68K
-0.44%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
473.51K
0.82%
+4.73K
+1.01%
Feb 28, 2026
Acadian Asset Management LLC
314.02K
0.54%
+39.89K
+14.55%
Dec 31, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
Avantis International Small Cap Equity ETF
0.01%
DFA Dimensional International Small Cap ETF
0.01%
Dimensional International Core Equity Market ETF
0%
ARK Israel Innovative Technology ETF
0%
Avantis International Equity ETF
0%
Vanguard Total World Stock Index Fund
0%
Vanguard ESG International Stock ETF
0%
Schwab International Small-Cap Equity ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
DFA Dimensional International Small Cap Value ETF
0%
Avantis International Small Cap Equity ETF
æ¯ç0.01%
DFA Dimensional International Small Cap ETF
æ¯ç0.01%
Dimensional International Core Equity Market ETF
æ¯ç0%
ARK Israel Innovative Technology ETF
æ¯ç0%
Avantis International Equity ETF
æ¯ç0%
Vanguard Total World Stock Index Fund
æ¯ç0%
Vanguard ESG International Stock ETF
æ¯ç0%
Schwab International Small-Cap Equity ETF
æ¯ç0%
DFA Dimensional International Core Equity 2 ETF
æ¯ç0%
DFA Dimensional International Small Cap Value ETF
æ¯ç0%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
